Presented by Mark Pletcher, MD, MPH, at UCSF's symposium "The Role of Risk Stratification and Biomarkers in Prevention of Cardiovascular Disease" in Jan 2012.
OK, let’s get started. We’re going to spend the morning talking about the role of risk stratification and biomarkers in prevention of CVD.
Nearly 50,000 articles in PubMed on “Cardiovascular Diseases” and “biomarker”, but not one post-Framingham biomarker has completed translation into routine clinical practice